SEC Form 4 · accession 0001562180-17-000302
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Aaron Lehman
Officer — General Counsel
Period of report
Jan 18, 2017
Accepted (ET)
Jan 20, 2017 · 7:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 18, 2017 | A | 9,000 | $0.00 | A | 9,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F2 | $13.05 | Jan 18, 2017 | A | 42,000 | A | — | Jan 17, 2027 | Common Stock | 42,000 | 42,000 | D |
Explanation of responses
- F1Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest in equal annual installments over three years commencing on January 1, 2017.
- F21/8th of the shares subject to the option vest on July 1, 2017 and 1/48th of the total shares subject to the option vest monthly thereafter over 42 months.